envista holdings corp. - NVST

NVST

Close Chg Chg %
25.90 -0.09 -0.33%

Closed Market

25.82

-0.09 (0.33%)

Volume: 1.70M

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: envista holdings corp. - NVST

NVST Key Data

Open

$24.87

Day Range

24.87 - 26.20

52 Week Range

14.23 - 30.42

Market Cap

$4.23B

Shares Outstanding

163.88M

Public Float

160.22M

Beta

0.99

Rev. Per Employee

N/A

P/E Ratio

92.91

EPS

$0.28

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.41M

 

NVST Performance

1 Week
 
4.92%
 
1 Month
 
-3.91%
 
3 Months
 
18.99%
 
1 Year
 
66.73%
 
5 Years
 
-36.79%
 

NVST Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 14
Full Ratings ➔

About envista holdings corp. - NVST

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It offers dental consumables, equipment, and services to dental professionals. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures, and markets dental implant systems, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments refers to developing, manufacturing, and marketing dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems, and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. The company was founded on August 29, 2018 and is headquartered in Brea, CA.

NVST At a Glance

Envista Holdings Corp.
200 South Kraemer Boulevard
Brea, California 92821
Phone 1-714-817-7000 Revenue 2.72B
Industry Medical Specialties Net Income 47.00M
Sector Health Technology 2025 Sales Growth 8.321%
Fiscal Year-end 12 / 2026 Employees 12,000
View SEC Filings

NVST Valuation

P/E Current 92.909
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 78.15
Price to Sales Ratio 1.351
Price to Book Ratio 1.145
Price to Cash Flow Ratio 13.32
Enterprise Value to EBITDA 11.232
Enterprise Value to Sales 1.493
Total Debt to Enterprise Value 0.394

NVST Efficiency

Revenue/Employee 226,625.00
Income Per Employee 3,916.667
Receivables Turnover 6.33
Total Asset Turnover 0.485

NVST Liquidity

Current Ratio 2.377
Quick Ratio 2.039
Cash Ratio 1.421

NVST Profitability

Gross Margin 55.021
Operating Margin 9.024
Pretax Margin 6.516
Net Margin 1.728
Return on Assets 0.838
Return on Equity 1.556
Return on Total Capital 0.999
Return on Invested Capital 1.045

NVST Capital Structure

Total Debt to Total Equity 51.434
Total Debt to Total Capital 33.965
Total Debt to Total Assets 27.697
Long-Term Debt to Equity 50.179
Long-Term Debt to Total Capital 33.136
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Envista Holdings Corp. - NVST

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.57B 2.57B 2.51B 2.72B
Sales Growth
+2.40% -0.10% -2.18% +8.32%
Cost of Goods Sold (COGS) incl D&A
1.08B 1.12B 1.13B 1.22B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
162.10M 162.60M 123.10M 116.00M
Depreciation
56.10M 63.00M 40.80M 40.10M
Amortization of Intangibles
106.00M 99.60M 82.30M 75.90M
COGS Growth
+4.34% +3.27% +1.43% +8.06%
Gross Income
1.49B 1.45B 1.38B 1.50B
Gross Income Growth
+1.03% -2.55% -4.96% +8.54%
Gross Profit Margin
+57.93% +56.52% +54.91% +55.02%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.12B 1.13B 1.24B 1.25B
Research & Development
100.10M 93.80M 99.10M 114.00M
Other SG&A
1.02B 1.03B 1.14B 1.14B
SGA Growth
+4.05% +0.76% +9.76% +1.25%
Other Operating Expense
- - - -
-
Unusual Expense
52.10M 321.90M 1.18B 29.30M
EBIT after Unusual Expense
319.20M 3.00M (1.04B) 216.10M
Non Operating Income/Expense
3.10M 5.50M (100.00K) (2.30M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
38.40M 63.40M 46.40M 36.60M
Interest Expense Growth
-29.02% +65.10% -26.81% -21.12%
Gross Interest Expense
38.40M 63.40M 46.40M 36.60M
Interest Capitalized
- - - -
-
Pretax Income
283.90M (54.90M) (1.08B) 177.20M
Pretax Income Growth
+11.55% -119.34% -1,875.77% +116.34%
Pretax Margin
+11.05% -2.14% -43.20% +6.52%
Income Tax
45.90M 45.30M 33.90M 130.20M
Income Tax - Current - Domestic
51.10M 37.80M 15.40M 51.00M
Income Tax - Current - Foreign
22.40M 44.50M 47.90M 66.70M
Income Tax - Deferred - Domestic
(38.90M) (33.60M) (38.00M) 19.40M
Income Tax - Deferred - Foreign
11.30M (3.40M) 8.60M (6.90M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
238.00M (100.20M) (1.12B) 47.00M
Minority Interest Expense
- - - -
-
Net Income
238.00M (100.20M) (1.12B) 47.00M
Net Income Growth
-9.68% -142.10% -1,016.37% +104.20%
Net Margin Growth
+9.26% -3.90% -44.56% +1.73%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
238.00M (100.20M) (1.12B) 47.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
238.00M (100.20M) (1.12B) 47.00M
EPS (Basic)
1.461 -0.6004 -6.4959 0.2798
EPS (Basic) Growth
-28.37% -141.10% -981.93% +104.31%
Basic Shares Outstanding
162.90M 166.90M 172.20M 168.00M
EPS (Diluted)
1.3401 -0.6004 -6.4959 0.2778
EPS (Diluted) Growth
-27.62% -144.80% -981.93% +104.28%
Diluted Shares Outstanding
177.60M 166.90M 172.20M 169.20M
EBITDA
533.40M 487.50M 266.20M 361.40M
EBITDA Growth
-3.28% -8.61% -45.39% +35.76%
EBITDA Margin
+20.76% +18.99% +10.60% +13.29%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 28.462
Number of Ratings 14 Current Quarters Estimate 0.32
FY Report Date 06 / 2026 Current Year's Estimate 1.41
Last Quarter’s Earnings 0.31 Median PE on CY Estimate N/A
Year Ago Earnings 1.19 Next Fiscal Year Estimate 1.56
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 14 14 14 14
Mean Estimate 0.32 0.36 1.41 1.56
High Estimates 0.36 0.38 1.44 1.62
Low Estimate 0.27 0.33 1.36 1.51
Coefficient of Variance 6.61 3.82 1.51 2.14

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 3
OVERWEIGHT 2 2 2
HOLD 7 7 10
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Envista Holdings Corp. in the News